Global Short-read Sequencing Market: Size, Share & Trends Analysis Report 2019-2025HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global Short-read Sequencing Market: Size, Share & Trends Analysis Report 2019-2025GlobeNewswireJanuary 3, 2020ReblogShareTweetShareDublin, Jan. 03, 2020 (GLOBE NEWSWIRE) -- The "Short-read Sequencing Market Size, Share & Trends Analysis Report By Technology (Next Generation Sequencing, Sanger Sequencing), By Product, By Application, By End Use, By Workflow, And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering. The global short-read sequencing market size is expected to reach USD 18.64 billion by 2025, at a CAGR of 11.32%.Rising demand for personalized medicine and companion diagnostics is anticipated to drive the growth.In addition, initiatives taken by key players to enhance their market presence are expected to boost revenue generation in the market for short-read sequencing. For instance, in March 2019, Illumina partnered with Boai NKY Medical Holdings, a China-based producer of polyvinylpyrrolidone, to develop NGS-based systems for in-vitro diagnosis of hereditary diseases. The novel systems would be developed by using NKY's library prep kits and analysis software and Illumina's MiniSeq system.Other major market players have also entered into partnerships and collaborations for expansion in the Asian market as Asia Pacific offers a wide customer-base of patients suffering from chronic disorders that can be diagnosed easily using sequencing methods.Major application areas of short-read sequencing include reproductive screening, oncology, noninvasive prenatal testing, infectious disease, and pharmacogenomics. A rise in adoption of sequencing platforms for diagnosis of the aforementioned clinical conditions is expected to have a positive impact on the overall market growth.Further key findings from the report suggest:Next-generation Sequencing (NGS) accounted for the largest revenue share in 2018 and is expected to maintain its dominance over the forecast period, owing to the presence of substantial platforms and services offered by prominent participants in NGS is anticipated to add to the market revenueConsumables product segment is expected to witness lucrative growth over the forecast period, since these products are short-lived and exhibit higher usabilityShort read methods are most commonly adopted in the field of oncology owing to an increase in the adoption of NGS technology to advance personalized treatment for different types of cancerSequencing step dominated with the largest market share in 2018 as it is the important step of the protocols implemented in terms of time as well as consumablesAcademic research held the largest market share in 2018 as a consequence of higher usage of these protocols in research, academic workshops, and on-site bioinformatics courses offered by universitiesIllumina, Inc.; Thermo Fisher Scientific Inc.; 10x Genomics; and Qiagen N.V. are the prominent participants operating in the short-read sequencing market. These participants engage in new product development and strategic alliances to maintain the market shareCompanies ProfiledThermo Fisher Scientific Inc.F. Hoffmann-La Roche AGIllumina Inc.GenewizGenscript Biotech Corporation10x GenomicsMacrogen Inc.Qiagen N.V.Agilent TechnologiesBGI GenomicsFasteris S.A.GE HealthcareFor more information about this report visit https://www.researchandmarkets.com/r/pbb3c1Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextLatin America roundup: SoftBank adds $1B, Stori raises $10M and Grow Mobility puts on the brakesTechCrunch4 Giants See Stocks Plummet on Coronavirus WarningsGuruFocus.comTrade Desk Tops Earnings Views, Sets Higher Investments In Internet TVInvestor's Business DailyWalmart’s Answer to Amazon Prime? Walmart+Footwear NewsBudweiser Brewer Shares Dive as It Loses More U.S. Market ShareThe Wall Street JournalRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance